Literature DB >> 15647035

Occupational hypersensitivity to metal salts, including platinum, in the secondary industry.

A Cristaudo1, F Sera, V Severino, M De Rocco, E Di Lella, M Picardo.   

Abstract

BACKGROUND: Exposure to platinum group elements (PGEs) - platinum (Pt), palladium (Pd), rhodium (Rh) and iridium (Ir) - may cause acute toxicity or hypersensitivity with respiratory symptoms, urticaria and (less frequently) contact dermatitis. Our aim was to determine the prevalence and the clinical characteristics of hypersensitivity to platinum salts and to other elements of the platinum group.
METHODS: A total of 153 subjects working in a catalyst manufacturing and recycling factory were examined. The examination consisted of a work exposure and medical questionnaire, physical examination, skin prick test for PGEs and other common aeroallergens, and patch tests for PGEs. Skin prick tests and patch tests were performed with H(2)[PtCl(6)], K(2)[PtCl(4)], Na(2)[PtCl(6)], IrCl(3), RhCl(3), PdCl(2), aqueous solutions at different concentrations.
RESULTS: Positive prick test reactions to Pt-salts at various concentrations were found in 22 (14.4%) of 153 workers; eight had simultaneous reactions to all Pt-salts tested; seven had positive responses to H(2)[PtCl(6)] only; four had simultaneous positive reactions to both H(2)[PtCl(6)] and K(2)[PtCl(4)]; three had positive reactions to H(2)[PtCl(6)] and Na(2)[PtCl(6)]. Three of 22 had positive reactions to H(2)[PtCl(6)] and IrCl(3) solutions, two of these had positive reactions to H(2)[PtCl(6)], IrCl(3) and RhCl(3) solutions. Positive patch test reactions to platinum salts at day 2 were seen in two of 153 subjects.
CONCLUSIONS: The results of this study demonstrate that Pt-salts are important allergens in the catalyst industry and that the clinical manifestations involve both the respiratory system and the skin. Hexachloroplatinic acid should be considered the most important salt to use for skin prick tests.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15647035     DOI: 10.1111/j.1398-9995.2004.00521.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  6 in total

1.  Biomonitoring of tram drivers exposed to airborne platinum, rhodium and palladium.

Authors:  Ivo Iavicoli; Beatrice Bocca; Giovanni Carelli; Sergio Caroli; Stefano Caimi; Alessandro Alimonti; Luca Fontana
Journal:  Int Arch Occup Environ Health       Date:  2007-05-11       Impact factor: 3.015

2.  Sub-Chronic Oral Exposure to Iridium (III) Chloride Hydrate in Female Wistar Rats: Distribution and Excretion of the Metal.

Authors:  Ivo Iavicoli; Luca Fontana; Antonio Bergamaschi; Marcelo Enrique Conti; Anna Pino; Daniela Mattei; Beatrice Bocca; Alessandro Alimonti
Journal:  Dose Response       Date:  2012-01-16       Impact factor: 2.658

3.  ROS-Mediated Apoptosis and Genotoxicity Induced by Palladium Nanoparticles in Human Skin Malignant Melanoma Cells.

Authors:  Saud Alarifi; Daoud Ali; Saad Alkahtani; Rafa S Almeer
Journal:  Oxid Med Cell Longev       Date:  2017-07-16       Impact factor: 6.543

4.  Paclitaxel-loaded iron platinum stealth immunomicelles are potent MRI imaging agents that prevent prostate cancer growth in a PSMA-dependent manner.

Authors:  Robert M Taylor; Laurel O Sillerud
Journal:  Int J Nanomedicine       Date:  2012-08-06

Review 5.  EAACI position paper on occupational rhinitis.

Authors:  Gianna Moscato; Olivier Vandenplas; Roy Gerth Van Wijk; Jean-Luc Malo; Luca Perfetti; Santiago Quirce; Jolanta Walusiak; Roberto Castano; Gianni Pala; Denyse Gautrin; Hans De Groot; Ilenia Folletti; Mona Rita Yacoub; Andrea Siracusa
Journal:  Respir Res       Date:  2009-03-03

6.  Nickel, palladium and rhodium induced IFN-gamma and IL-10 production as assessed by in vitro ELISpot-analysis in contact dermatitis patients.

Authors:  Valentina Bordignon; Francesca Palamara; Paola Cordiali-Fei; Antonella Vento; Arianna Aiello; Mauro Picardo; Fabrizio Ensoli; Antonio Cristaudo
Journal:  BMC Immunol       Date:  2008-05-15       Impact factor: 3.615

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.